Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Genetic Variants at 20p11 Confer Risk to Androgenetic Alopecia in the Chinese Han Population

  • Bo Liang ,

    Contributed equally to this work with: Bo Liang, Chunjun Yang, Xianbo Zuo, Yang Li

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Chunjun Yang ,

    Contributed equally to this work with: Bo Liang, Chunjun Yang, Xianbo Zuo, Yang Li

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Xianbo Zuo ,

    Contributed equally to this work with: Bo Liang, Chunjun Yang, Xianbo Zuo, Yang Li

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Yang Li ,

    Contributed equally to this work with: Bo Liang, Chunjun Yang, Xianbo Zuo, Yang Li

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Yantao Ding,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Yujun Sheng,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Fusheng Zhou,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Hui Cheng,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Xiaodong Zheng,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Gang Chen,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Zhengwei Zhu,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Jun Zhu,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Xuhui Fu,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Tao Wang,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Ying Dong,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Dawei Duan,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Xianfa Tang,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Huayang Tang,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Jinping Gao,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Liangdan Sun,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • Sen Yang,

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  •  [ ... ],
  • Xuejun Zhang

    ayzxj@vip.sina.com

    Affiliations Institute of Dermatology and Department of Dermatology, No.1 Hospital, Anhui Medical University, Hefei, Anhui, China, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, Anhui, China, State key Laboratory Incubation Base of Dermatology, Anhui Medical University, Hefei, Anhui, China

  • [ view all ]
  • [ view less ]

Abstract

Background

Androgenetic alopecia (AGA) is a well-characterized type of progressive hair loss commonly seen in men, with different prevalences in different ethnic populations. It is generally considered to be a polygenic heritable trait. Several susceptibility genes/loci, such as AR/EDA2R, HDAC9 and 20p11, have been identified as being involved in its development in European populations. In this study, we aim to validate whether these loci are also associated with AGA in the Chinese Han population.

Methods

We genotyped 16 previously reported single nucleotide polymorphisms (SNPs) with 445 AGA cases and 546 healthy controls using the Sequenom iPlex platform. The trend test was used to evaluate the association between these loci and AGA in the Chinese Han population. Conservatively accounting for multiple testing by the Bonferroni correction, the threshold for statistical significance was P ≤3.13×10−3.

Results

We identified that 5 SNPs at 20p11 were significantly associated with AGA in the Chinese Han population (1.84×10−11≤P≤2.10×10−6).

Conclusions

This study validated, for the first time, that 20p11 also confers risk for AGA in the Chinese Han population and implicated the potential common genetic factors for AGA shared by both Chinese and European populations.

Introduction

Androgenetic alopecia (AGA) is a common disease that is characterized by a distinctive pattern of progressive hair loss from the scalp. The proportion of affected males increases steadily with age, and its high prevalence in older men suggests that this form of hair loss may be a normal consequence of aging [1], [2]. The prevalence of AGA is different among races. The prevalence of AGA in Chinese males is lower than in Caucasians at all ages [3], [4].

The etiology of AGA was first described by Hamilton, including two essential components: genetic predisposition and hormone dependency [5], [6]. So far, several genetic factors, such as the androgen receptor (AR)/the ectodysplasin A2 receptor (EDA2R) [7][10], histone deacetylase 9 (HDAC9) [11] and 20p11 [12], [13], have been identified as being associated with this disorder. The present study aims to investigate whether the known susceptibility loci for the European populations are also associated with AGA in the Chinese Han population by the investigation of 8 SNPs at HDAC9 [11], 5 SNPs on 20p11 [13] and 3 SNPs at the AR/EDA2R locus [9], [10].

Materials and Methods

Samples and DNA extraction

This investigation involved samples from 445 affected cases and 546 controls. All participants were males of Chinese Han descent (Table 1). The hair status of all participants was assessed by dermatologists according to the Hamilton/Norwood (HN) classification system. Affected men were <30 years of age with AGA grades IV–VII or <40 years with AGA grades V–VII. The controls comprised 546 unaffected male controls aged >60 years. Blood samples were collected in tubes containing disodium ethylene diamine tetraacetic acid (EDTA) as an anticoagulant and stored at −80°C until extraction. Genomic DNA was extracted from peripheral blood lymphocytes using Flexi Gene DNA kits (Qiagen, Hilden, Germany) according to standard procedures and diluted to working concentrations of 20 ng/μl for the replication study of the findings in the European population. All the samples were obtained after written informed consent. The study was approved by the Ethics Committee of Anhui Medical University and conducted according to Declaration of Helsinki Principles.

Genotyping

Genotyping was performed in multiplex reactions using the MassArray system and a Sequenom Compact MALDI-TOF device (Sequenom Inc., San Diego, CA, U.S.A.) at the Key Lab of Dermatology, Ministry of Education, Anhui Medical University, China. For the association analysis, the minor allele frequency (MAF) was ≥1% with P ≥0.05 for Hardy-Weinberg equilibrium in the controls, and SNPs with call rates higher than 95% in cases or controls were used for the SNP quality criteria.

Statistical analysis

For the association testing, the Armitage trend test was used to detect allelic and genotypic effects using Plink 1.07 software (Harvard, Boston, MA, USA). The power was calculated using the power Fisher exact test in SPSS (SPSS version 13.0). In total, 16 SNPs were genotyped in 445 cases and 546 controls. Conservatively accounting for multiple testing by the Bonferroni correction, the threshold for statistical significance was P≤3.13×10−3.

Results

Overall, we genotyped 16 SNPs in this study, which was performed in 445 AGA cases and 546 controls of Chinese Han descent using the Sequenom MassArray system. As shown in Table 2, the 3 SNPs (rs1385699, rs2497911, rs5919393) of the AR/EDA2R locus, which shows significant association with AGA in European populations, were monomorphic in the Chinese population. The 8 SNPs of the HDAC9 locus, which reported susceptibility to AGA from a previous GWAS in European populations, showed no significance in the Chinese Han Population. After the initial analysis using the Armitage trend test, 5 SNPs (rs2180439, rs1998076, rs6113491, rs6137444 and rs201571) were significantly associated with AGA, exceeding the threshold of statistical significance for association (P<3.13×10−3).These five AGA susceptibility SNPs identified in the Chinese population are associated with one genetic locus (20p11). The SNP rs2180439 showed a stronger association (OR  = 1.92, P = 1.84×10−11) than the other four SNPs. Furthermore, controlling for the genetic effect of the SNP rs2180439 by using conditional logistic regression analysis also abolished the association of the other four SNPs (P>0.05, Table 3). These findings indicate that the other four SNP alleles are correlated with the SNP rs2180439 and that the association of the other four SNPs is mainly driven by the SNP rs2180439. The difference in the distribution of the rs2180439 genotype between the AGA cases and controls was significant (P = 1.29×10−10) (Table 4).

thumbnail
Table 2. Case-control association analysis for SNPs within AR/EDA2R, HDAC9 and 20p11 in 445 Han Chinese patients with AGA and 546 controls.

https://doi.org/10.1371/journal.pone.0071771.t002

thumbnail
Table 3. Association and conditional logistic analysis for rs2180439, rs6137444, rs1998076, rs201571 and rs6113491 in 445 cases and 546 controls.

https://doi.org/10.1371/journal.pone.0071771.t003

thumbnail
Table 4. Genotypic effects analysis for rs2180439 in the AGA patients and controls.

https://doi.org/10.1371/journal.pone.0071771.t004

Discussion

This study is the first to investigate the contribution of the major AGA susceptibility loci AR/ EDA2R, 20p11 and HDAC9 to the development of AGA in the Chinese Han population.

In this study, we confirmed that the susceptibility locus 20p11 for AGA in the Chinese Han population, which suggested the existence of common genetic factors shared for AGA in diverse ethnic populations. Because a gene contributing to the development of AGA would be expected to be expressed in the human scalp, Hillmer AM et al quantified the gene expression of the 20p11 locus and the expression of the closest paired box 1 (PAX1) gene [13]. The results showed that PAX1 was expressed at very high levels in the scalp skin. Although the PAX1 gene is more than 100 kb away from the 20p11–associated LD block, the expression data might suggest that PAX1 confers the AGA-relevant effect at this locus and that a regulatory variant within the associated LD block may modulate its expression through long-range control. However, demonstration of the influence of the chromosome 20p11.22 locus on the transcription of the PAX1 gene requires further investigation.

For the HDAC9 locus, the statistical power calculations showed that we had >80% power to detect 5 SNPs (rs13230142, rs12056282, rs756853, rs2249817 and rs10247184) associated with AGA, whereas other 3 SNPs (rs3852255, rs10252945 and rs17350355) had low power (≤70%), with SNP rs17350355 having the lowest power (36%). For those SNPs that had low power to detect an association, we could not confirm that these SNPs lacked an association with AGA because we might lack the power to detect a true association. Larger sample sizes will help improve the power and ensure the correct conclusion with respect to whether these SNP are associated with AGA. For those SNPs that had >80% power to detect an association, we confirmed that these SNPs are not associated with AGA; however, we do not deny that HDAC9 may be a risk factor for AGA because there could be different functional variants between Chinese and Caucasian populations or different LD patterns between the markers and hidden functional variants. For the AR/EDA2R locus, our genotype data showed that the three SNPs (rs1385699, rs2497911 and rs5919393) of the AR/EDA2R locus that show significant association with AGA in European populations were monomorphic in the Chinese population. These results showed that there is genetic heterogeneity among different populations. Genotyping other known SNPs in these region according to HapMap data will help elucidate the basis for potential ethnicity-related disparities in the AGA association for previously reported loci (HDAC9 and AR/EDA2R) among different populations, which will provide a better understanding of the genetic basis of AGA.

Taken together, our study provided strong genetic evidence for the hypothesis that 20p11 might influence the susceptibility to AGA in both the Chinese Han and European populations, although the role of the 20p11 locus in the pathogenesis of AGA remains unclear. Further study using fine mapping and a functional study are warranted to investigate its exact role in the pathogenesis of AGA.

Acknowledgments

We thank all study participants and all volunteers who so willingly participated in this study, thus making this study possible.

Author Contributions

Performed the experiments: BL JZ GC FSZ YTD. Analyzed the data: XBZ YL XDZ. Contributed reagents/materials/analysis tools: HYT YJS HC SY XFT. Wrote the paper: LDS BL YL. Participated with aspects of study design and interpretation of the datas: XHF TW Y. Dong ZWZ JPG DWD. Conceived this study and obtained financial support: CJY XJZ. Designed the experiments: CJY XJZ BL XBZ YL.

References

  1. 1. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53: 708–728.
  2. 2. Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J 68: 1359–1365.
  3. 3. Wang TL, Zhou C, Shen YW, Wang XY, Ding XL, et al. (2010) Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 162: 843–847.
  4. 4. Xu F, Sheng YY, Mu ZL, Lou W, Zhou J, et al. (2009) Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 160: 629–32.
  5. 5. Trueb RM (2010) [Hormones and hair growth]. Hautarzt 61: 487–495.
  6. 6. Chumlea WC, Rhodes T, Girman CJ, Johnson-Levonas A, Lilly FR, et al. (2004) Family history and risk of hair loss. Dermatology 209: 33–39.
  7. 7. Brockschmidt FF, Hillmer AM, Eigelshoven S, Hanneken S, Heilmann S, et al. (2010) Fine mapping of the human AR/EDA2R locus in androgenetic alopecia. Br J Dermatol 162: 899–903.
  8. 8. Prodi DA, Pirastu N, Maninchedda G, Sassu A, Picciau A, et al. (2008) EDA2R is associated with androgenetic alopecia. J Invest Dermatol 128: 2268–2270.
  9. 9. Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, et al. (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 77: 140–148.
  10. 10. Cobb JE, Zaloumis SG, Scurrah KJ, Harrap SB, Ellis JA (2010) Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene. Exp Dermatol 19: 1026–8.
  11. 11. Brockschmidt FF, Heilmann S, Ellis JA, Eigelshoven S, Hanneken S, et al. (2011) Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness. Br J Dermatol 165: 1293–1302.
  12. 12. Richards JB, Yuan X, Geller F, Waterworth D, Bataille V, et al. (2008) Male-pattern baldness susceptibility locus at 20p11. Nat Genet 40: 1282–1284.
  13. 13. Hillmer AM, Brockschmidt FF, Hanneken S, Eigelshoven S, Steffens M, et al. (2008) Susceptibility variants for male-pattern baldness on chromosome 20p11. Nat Genet 40: 1279–1281.